相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 保质期:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 英文名:
CAY-10602
- 库存:
现询
- 供应商:
北京索莱宝科技有限公司
- CAS号:
374922-43-7
- 规格:
100mg/50mg/10mg/5mg
| 规格: | 100mg | 产品价格: | ¥3290.0 |
|---|---|---|---|
| 规格: | 50mg | 产品价格: | ¥1890.0 |
| 规格: | 10mg | 产品价格: | ¥613.0 |
| 规格: | 5mg | 产品价格: | ¥440.0 |
CAY10602是有效的SIRT1激活剂。
| 基本信息 | |
| CAS | No.374922-43-7 |
| 英文名称 | CAY-10602 |
| 别名 | 1-(4-PhF基)-3-(苯磺酰基)-1H-C4H5N并[2,3-B]喹喔啉-2-胺 |
| 分子式 | C22H15FN4O2S |
| 分子量 | 418.44 |
| 溶解性 | Soluble in DMSO |
| 纯度 | ≥98% |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
| MDL | MFCD02236691 |
| SMILES | NC1=C(S(=O)(C2=CC=CC=C2)=O)C3=NC4=CC=CC=C4N=C3N1C5=CC=C(F)C=C5 |
| 靶点 | SIRT1 |
| 通路 | Cell Cycle;DNA Damage/DNA Repair; Epigenetics |
| 背景说明 | CAY10602是有效的SIRT1激活剂。 |
| 生物活性 | CAY10602 is a SIRT1 activator. CAY10602 dose-dependently suppresses the NF-κB-dependent induction of TNF-α by lipopolysaccharide in THP-1 cells[1]. |
| In Vitro | Compounds (including CAY10602/compound 1) with SIRT1-activating properties have a significant effect on fat mobilization in differentiated adipocytes, and these compounds (including CAY10602) have antiobesity and/or antidiabetic properties. Compounds (including CAY10602) with SIRT1 activating potential exert strong suppression of TNF-α release at concentrations between 20 and 60 μM[1]. |
| 细胞实验 | 3T3L1 mouse fibroblasts and THP-1 leukemia cells are used and cultured following the suppliers recommendations.THP-1 cells are treated first with representative compounds (including CAY10602/compound 1) followed by addition of lipopolysaccharide(LPS). THP-1 cells are plated at a density of 1.2×106 cells/mL in 0.4 mL (0.5×106 cells/treatment) in 24-well culture plates. The cells are preincubated with representative test compounds (including CAY10602) at 2 concentrations (20 or 60 μM) for 1 h under general tissue culture conditions[1]. |
| 数据来源文献 | [1]. Nayagam VM, et al. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen. 2006 Dec;11(8):959-67. |
| 单位 | 瓶 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验DMSO,在脱色摇床上振荡10分钟,然后测吸光值。一般要低于IC50,避免非调亡性杀伤的细胞太多,造成流式细胞仪检测碎片太多。我一般用1/2-1/3的IC50,作用时间为36h。一般肿瘤细胞系空白处理的调亡率应低于1%,用药后一般为5-10%(Annexin V),细胞周期的亚G0峰比较明显。
ul,作用四小时后洗掉上清液,注意不要将甲瓉洗掉,然后每孔加150ul DMSO,在脱色摇床上振荡10分钟,然后测吸光值。 一般要低于IC50,避免非调亡性杀伤的细胞太多,造成流式细胞仪检测碎片太多。我一般用1/2-1/3的IC50,作用时间为36h。一般肿瘤细胞系空白处理的调亡率应低于1%,用药后一般为5-10%(Annexin V),细胞周期的亚G0峰比较明显。
不要将甲瓉洗掉,然后每孔加150μl DMSO,在脱色摇床上振荡10分钟,然后测吸光值。一般要低于IC50,避免非调亡性杀伤的细胞太多,造成流式细胞仪检测碎片太多。我一般用1/2-1/3的IC50,作用时间为36h。一般肿瘤细胞系空白处理的调亡率应低于1%,用药后一般为5-10%(Annexin V),细胞周期的亚G0峰比较明显。有一点看法:我觉得做任何实验都需要摸索适合你的实验的条件,不能用一个protocol去套所有的实际。拿MTT来说,这个实验是间接检测活细胞数目的,而需要确定活
技术资料暂无技术资料 索取技术资料










